258 related articles for article (PubMed ID: 32459082)
1. Hybrid Magnetic Nanovectors Promote Selective Glioblastoma Cell Death through a Combined Effect of Lysosomal Membrane Permeabilization and Chemotherapy.
Pucci C; De Pasquale D; Marino A; Martinelli C; Lauciello S; Ciofani G
ACS Appl Mater Interfaces; 2020 Jul; 12(26):29037-29055. PubMed ID: 32459082
[TBL] [Abstract][Full Text] [Related]
2. Nutlin-loaded magnetic solid lipid nanoparticles for targeted glioblastoma treatment.
Grillone A; Battaglini M; Moscato S; Mattii L; de Julián Fernández C; Scarpellini A; Giorgi M; Sinibaldi E; Ciofani G
Nanomedicine (Lond); 2019 Mar; 14(6):727-752. PubMed ID: 30574827
[TBL] [Abstract][Full Text] [Related]
3. Stimuli-responsive lipid-based magnetic nanovectors increase apoptosis in glioblastoma cells through synergic intracellular hyperthermia and chemotherapy.
Tapeinos C; Marino A; Battaglini M; Migliorin S; Brescia R; Scarpellini A; De Julián Fernández C; Prato M; Drago F; Ciofani G
Nanoscale; 2018 Dec; 11(1):72-88. PubMed ID: 30357214
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound-responsive nutlin-loaded nanoparticles for combined chemotherapy and piezoelectric treatment of glioblastoma cells.
Pucci C; Marino A; Şen Ö; De Pasquale D; Bartolucci M; Iturrioz-Rodríguez N; di Leo N; de Vito G; Debellis D; Petretto A; Ciofani G
Acta Biomater; 2022 Feb; 139():218-236. PubMed ID: 33894347
[TBL] [Abstract][Full Text] [Related]
5. A Novel Patient-Personalized Nanovector Based on Homotypic Recognition and Magnetic Hyperthermia for an Efficient Treatment of Glioblastoma Multiforme.
De Pasquale D; Pucci C; Desii A; Marino A; Debellis D; Leoncino L; Prato M; Moscato S; Amadio S; Fiaschi P; Prior A; Ciofani G
Adv Healthc Mater; 2023 Jul; 12(19):e2203120. PubMed ID: 37058273
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional temozolomide-loaded lipid superparamagnetic nanovectors: dual targeting and disintegration of glioblastoma spheroids by synergic chemotherapy and hyperthermia treatment.
Marino A; Camponovo A; Degl'Innocenti A; Bartolucci M; Tapeinos C; Martinelli C; De Pasquale D; Santoro F; Mollo V; Arai S; Suzuki M; Harada Y; Petretto A; Ciofani G
Nanoscale; 2019 Nov; 11(44):21227-21248. PubMed ID: 31663592
[TBL] [Abstract][Full Text] [Related]
7. A Combined Approach Employing Chlorotoxin-Nanovectors and Low Dose Radiation To Reach Infiltrating Tumor Niches in Glioblastoma.
Tamborini M; Locatelli E; Rasile M; Monaco I; Rodighiero S; Corradini I; Franchini MC; Passoni L; Matteoli M
ACS Nano; 2016 Feb; 10(2):2509-20. PubMed ID: 26745323
[TBL] [Abstract][Full Text] [Related]
8. Dual-targeting and excretable ultrasmall SPIONs for T
Du C; Liu X; Hu H; Li H; Yu L; Geng D; Chen Y; Zhang J
J Mater Chem B; 2020 Mar; 8(11):2296-2306. PubMed ID: 32100784
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic evaluation of magnetic hyperthermia using Fe3O4-aminosilane-coated iron oxide nanoparticles in glioblastoma animal model.
Rego GNA; Mamani JB; Souza TKF; Nucci MP; Silva HRD; Gamarra LF
Einstein (Sao Paulo); 2019 Aug; 17(4):eAO4786. PubMed ID: 31390427
[TBL] [Abstract][Full Text] [Related]
10. Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy.
Kadari A; Pooja D; Gora RH; Gudem S; Kolapalli VRM; Kulhari H; Sistla R
Eur J Pharm Biopharm; 2018 Nov; 132():168-179. PubMed ID: 30244167
[TBL] [Abstract][Full Text] [Related]
11. Angiopep-2-Functionalized Lipid Cubosomes for Blood-Brain Barrier Crossing and Glioblastoma Treatment.
Cai X; Refaat A; Gan PY; Fan B; Yu H; Thang SH; Drummond CJ; Voelcker NH; Tran N; Zhai J
ACS Appl Mater Interfaces; 2024 Mar; 16(10):12161-12174. PubMed ID: 38416873
[TBL] [Abstract][Full Text] [Related]
12. Brain and bone cancer targeting by a ferrofluid composed of superparamagnetic iron-oxide/silica/carbon nanoparticles (earthicles).
Wu VM; Huynh E; Tang S; Uskoković V
Acta Biomater; 2019 Apr; 88():422-447. PubMed ID: 30711662
[TBL] [Abstract][Full Text] [Related]
13. Recombinant interleukin-1 receptor antagonist conjugated to superparamagnetic iron oxide nanoparticles for theranostic targeting of experimental glioblastoma.
Shevtsov MA; Nikolaev BP; Yakovleva LY; Dobrodumov AV; Zhakhov AV; Mikhrina AL; Pitkin E; Parr MA; Rolich VI; Simbircev AS; Ischenko AM
Neoplasia; 2015 Jan; 17(1):32-42. PubMed ID: 25622897
[TBL] [Abstract][Full Text] [Related]
14. Retro-inverso isomer of Angiopep-2: a stable d-peptide ligand inspires brain-targeted drug delivery.
Wei X; Zhan C; Chen X; Hou J; Xie C; Lu W
Mol Pharm; 2014 Oct; 11(10):3261-8. PubMed ID: 24673510
[TBL] [Abstract][Full Text] [Related]
15. Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex.
Kang T; Jiang M; Jiang D; Feng X; Yao J; Song Q; Chen H; Gao X; Chen J
Mol Pharm; 2015 Aug; 12(8):2947-61. PubMed ID: 26149889
[TBL] [Abstract][Full Text] [Related]
16. Targeted Regulation of Blood-Brain Barrier for Enhanced Therapeutic Efficiency of Hypoxia-Modifier Nanoparticles and Immune Checkpoint Blockade Antibodies for Glioblastoma.
Meng L; Wang C; Lu Y; Sheng G; Yang L; Wu Z; Xu H; Han C; Lu Y; Han F
ACS Appl Mater Interfaces; 2021 Mar; 13(10):11657-11671. PubMed ID: 33684289
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Invasive Brain Tumors Using a Chain-like Nanoparticle.
Peiris PM; Abramowski A; Mcginnity J; Doolittle E; Toy R; Gopalakrishnan R; Shah S; Bauer L; Ghaghada KB; Hoimes C; Brady-Kalnay SM; Basilion JP; Griswold MA; Karathanasis E
Cancer Res; 2015 Apr; 75(7):1356-65. PubMed ID: 25627979
[TBL] [Abstract][Full Text] [Related]
18. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
Karim R; Palazzo C; Evrard B; Piel G
J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
[TBL] [Abstract][Full Text] [Related]
19. Highlights in targeted nanoparticles as a delivery strategy for glioma treatment.
Luiz MT; Delello Di Filippo L; Tofani LB; de Araújo JTC; Dutra JAP; Marchetti JM; Chorilli M
Int J Pharm; 2021 Jul; 604():120758. PubMed ID: 34090991
[TBL] [Abstract][Full Text] [Related]
20. Lysosomal membrane permeabilization by targeted magnetic nanoparticles in alternating magnetic fields.
Domenech M; Marrero-Berrios I; Torres-Lugo M; Rinaldi C
ACS Nano; 2013 Jun; 7(6):5091-101. PubMed ID: 23705969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
